
Kiesha Rose Bryant
Supervisory Patent Examiner (ID: 4107, Phone: (571)272-1844 , Office: P/2800 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2891, 2822 |
| Total Applications | 376 |
| Issued Applications | 266 |
| Pending Applications | 8 |
| Abandoned Applications | 102 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20163265
[patent_doc_number] => 20250255311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => INSECT NEUROPEPTIDES 4
[patent_app_type] => utility
[patent_app_number] => 19/180806
[patent_app_country] => US
[patent_app_date] => 2025-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19180806
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/180806 | INSECT NEUROPEPTIDES 4 | Apr 15, 2025 | Pending |
Array
(
[id] => 20163265
[patent_doc_number] => 20250255311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => INSECT NEUROPEPTIDES 4
[patent_app_type] => utility
[patent_app_number] => 19/180806
[patent_app_country] => US
[patent_app_date] => 2025-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19180806
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/180806 | INSECT NEUROPEPTIDES 4 | Apr 15, 2025 | Pending |
Array
(
[id] => 20177693
[patent_doc_number] => 20250261651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => INSECT NEUROPEPTIDES 3
[patent_app_type] => utility
[patent_app_number] => 19/090002
[patent_app_country] => US
[patent_app_date] => 2025-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19090002
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/090002 | INSECT NEUROPEPTIDES 3 | Mar 24, 2025 | Pending |
Array
(
[id] => 20232541
[patent_doc_number] => 20250289860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/052168
[patent_app_country] => US
[patent_app_date] => 2025-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19052168
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/052168 | POLYPEPTIDES AND USES THEREOF | Feb 11, 2025 | Pending |
Array
(
[id] => 20232541
[patent_doc_number] => 20250289860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/052168
[patent_app_country] => US
[patent_app_date] => 2025-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19052168
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/052168 | POLYPEPTIDES AND USES THEREOF | Feb 11, 2025 | Pending |
Array
(
[id] => 20005959
[patent_doc_number] => 20250144181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => COMPOSITION AND METHODS FOR REGULATING CHONDROCYTE PROLIFERATION AND INCREASING OF CARTILAGE MATRIX PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 19/016974
[patent_app_country] => US
[patent_app_date] => 2025-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19016974
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/016974 | COMPOSITION AND METHODS FOR REGULATING CHONDROCYTE PROLIFERATION AND INCREASING OF CARTILAGE MATRIX PRODUCTION | Jan 9, 2025 | Pending |
Array
(
[id] => 19477507
[patent_doc_number] => 20240325549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => GLP-1/GIP DUAL AGONIST, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/602255
[patent_app_country] => US
[patent_app_date] => 2024-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602255
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/602255 | GLP-1/GIP DUAL AGONIST, PREPARATION METHOD AND USE THEREOF | Mar 11, 2024 | Pending |
Array
(
[id] => 19593154
[patent_doc_number] => 12150972
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-11-26
[patent_title] => Egg white protein anti-inflammatory peptide and application thereof
[patent_app_type] => utility
[patent_app_number] => 18/600947
[patent_app_country] => US
[patent_app_date] => 2024-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 7047
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600947
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/600947 | Egg white protein anti-inflammatory peptide and application thereof | Mar 10, 2024 | Issued |
Array
(
[id] => 19675964
[patent_doc_number] => 12187814
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-01-07
[patent_title] => Stapled antimicrobial peptide
[patent_app_type] => utility
[patent_app_number] => 18/581115
[patent_app_country] => US
[patent_app_date] => 2024-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4529
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581115
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/581115 | Stapled antimicrobial peptide | Feb 18, 2024 | Issued |
Array
(
[id] => 19157718
[patent_doc_number] => 20240150425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => GIP AND GLP-1 DUAL RECEPTOR AGONIST, PHARMACEUTICAL COMPOSITION, AND USE
[patent_app_type] => utility
[patent_app_number] => 18/540219
[patent_app_country] => US
[patent_app_date] => 2023-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18540219
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/540219 | GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use | Dec 13, 2023 | Issued |
Array
(
[id] => 19504977
[patent_doc_number] => 12116388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Amylin receptor agonists
[patent_app_type] => utility
[patent_app_number] => 18/512512
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19842
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18512512
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/512512 | Amylin receptor agonists | Nov 16, 2023 | Issued |
Array
(
[id] => 19233744
[patent_doc_number] => 20240190936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => Incretin Analogs and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/497390
[patent_app_country] => US
[patent_app_date] => 2023-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497390
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/497390 | Incretin Analogs and Uses Thereof | Oct 29, 2023 | Pending |
Array
(
[id] => 19929718
[patent_doc_number] => 12302908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Insect neuropeptides 4
[patent_app_type] => utility
[patent_app_number] => 18/492058
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16341
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18492058
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/492058 | Insect neuropeptides 4 | Oct 22, 2023 | Issued |
Array
(
[id] => 18970424
[patent_doc_number] => 20240050516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII
[patent_app_type] => utility
[patent_app_number] => 18/379626
[patent_app_country] => US
[patent_app_date] => 2023-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379626
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379626 | PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII | Oct 11, 2023 | Pending |
Array
(
[id] => 18970424
[patent_doc_number] => 20240050516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII
[patent_app_type] => utility
[patent_app_number] => 18/379626
[patent_app_country] => US
[patent_app_date] => 2023-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379626
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379626 | PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII | Oct 11, 2023 | Pending |
Array
(
[id] => 18938131
[patent_doc_number] => 20240033270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/375639
[patent_app_country] => US
[patent_app_date] => 2023-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18375639
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/375639 | CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY | Oct 1, 2023 | Abandoned |
Array
(
[id] => 19003625
[patent_doc_number] => 20240067696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => GLUCAGON ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 18/371057
[patent_app_country] => US
[patent_app_date] => 2023-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18371057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/371057 | GLUCAGON ANALOGUES | Sep 20, 2023 | Pending |
Array
(
[id] => 19186332
[patent_doc_number] => 20240165245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/370695
[patent_app_country] => US
[patent_app_date] => 2023-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18370695
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/370695 | MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME | Sep 19, 2023 | Pending |
Array
(
[id] => 19187809
[patent_doc_number] => 20240166722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => MODIFIED PLASMA CLOTTING FACTOR VIII AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/468535
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18468535
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/468535 | MODIFIED PLASMA CLOTTING FACTOR VIII AND METHOD OF USE THEREOF | Sep 14, 2023 | Pending |
Array
(
[id] => 19002035
[patent_doc_number] => 20240066106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => HAEMORRHAGE INHIBITING COMPOSITIONS AND METHODS INVOLVING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/210190
[patent_app_country] => US
[patent_app_date] => 2023-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18210190
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/210190 | HAEMORRHAGE INHIBITING COMPOSITIONS AND METHODS INVOLVING THE SAME | Jun 14, 2023 | Pending |